A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
The Latest on: Motor neurone disease
via Google News
The Latest on: Motor neurone disease
- Sutton pensioner with motor neurone disease takes on big challenge on April 16, 2019 at 5:03 pm
A Sutton pensioner who defied doctors after he was diagnosed with a fatal and debilitating disease is taking on a huge challenge for charity. Colin de’Ath was told he had the terminal illness motor ... […]
- What happens in the bodies of ALS patients? on April 16, 2019 at 4:10 am
Muscle movement is controlled by specialised neurons called motor neurons. During the course of the disease, motor neurons gradually die. As ALS progresses, patients increasingly suffer from ... […]
- Shrewsbury teacher raises £10,000 for Motor Neurone Disease Association on April 16, 2019 at 2:09 am
A Shrewsbury teacher has raised more than £10,000 for charity through a series of fundraisers which culminates in running the London Marathon. Sam Ostermeyer is raising money for Motor Neurone Disease ... […]
- Daisy the dog makes silent woman with brain disease giggle again on April 15, 2019 at 4:46 am
Despite the disease, which her mother has described as "Parkinson’s, Motor Neurone Disease and Alzheimer’s all rolled into one devastating condition", Lizzie’s face has begun lighting up every time ... […]
- Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy on April 14, 2019 at 3:30 am
The ATP/GTP-Binding Protein 1 (AGTPBP1) gene (OMIM *606830) catalyzes deglutamylation of polyglutamylated proteins, and its deficiency manifests by cerebellar ataxia and peripheral neuropathy in mice ... […]
- Steph Houghton: Manchester City star hints she could miss World Cup if she needs to care for husband, who has motor neurone disease on April 8, 2019 at 9:13 am
Steph Houghton has suggested she would sacrifice her England World Cup spot to care for her husband, who has motor neurone disease. Houghton is captain of the England Lionesses and is currently ... […]
- England captain Steph Houghton hints she could sacrifice World Cup dream as ex-footballer husband Stephen Darby battles Motor Neurone Disease on April 8, 2019 at 6:41 am
Former Liverpool and Bolton defender Darby announced his retirement in September after he was diagnosed with Motor Neurone Disease The former Liverpool and Bolton defender, 30, announced his ... […]
- England captain Steph Houghton speaks out after her partner was diagnosed with motor neurone disease on April 6, 2019 at 11:04 am
Steph Houghton, captain of the England women’s football team, has spoken publicly for the first time about the devastating illness that ended her husband’s career in the game. Stephen Darby, 30, who ... […]
- Hong Kong Sevens: Doddie Weir talks motor neurone disease diagnosis, his calling and charity work on April 5, 2019 at 12:04 am
Scottish rugby legend Doddie Weir had a conversation with the man upstairs after he was diagnosed with motor neurone disease two and a half years ago. The progressive disease, which involves the ... […]
- Rugby star Doddie Weir tackles motor neurone disease with portrait on April 4, 2019 at 4:33 pm
A portrait of the former rugby star Doddie Weir raised about £80,000 at a fundraising dinner in Hong Kong. The portrait by Gerard M Burns was sold in aid of My Name’5 Doddie Foundation, which raises ... […]
via Bing News